Zhejiang Jiuzhou Pharmaceutical Co., Ltd
603456.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$14.38B
Close$
$8.46
49% downside
Current Fair Value
49% downsideOvervalued by 49% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $14.38 Billion |
|---|---|
| Enterprise Value | $13.06 Billion |
| Dividend Yield | $0.30 (1.23%) |
| Earnings per Share | $0.82 |
| Beta | 1.2 |
| Outstanding Shares | 879,425,295 |
Return
| Return on Equity | 6.65% |
|---|---|
| Return on Assets | 5.54% |
| Return on Invested Capital | 8.29% |
Valuation & Multiples
| P/E Ratio | 24.7 |
|---|---|
| PEG | -112.85 |
| Price to Sales | 3.32 |
| Price to Book Ratio | 1.66 |
| Enterprise Value to Revenue | 2.51 |
| Enterprise Value to EBIT | 17.06 |
| Enterprise Value to Net Income | 22 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$0.29
Average shareholder expectationRevenue Estimate
$1.38 B
Average shareholder expectationNext Earnings Call
Expected Date
October 22, 2026
EPS Estimate
$0.28
Average shareholder expectationRevenue Estimate
$1.38 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zhejiang Jiuzhou Pharmaceutical Co., Ltd
4,791 employees
CEO: Yi Jiang Mei Zhejiang Jiuzhou Pharmaceutical Co., Ltd, a company established in 1973 and operating from its headquarters in Taizhou, China, specializes in the production and global supply of active pharmaceutical ingredients (APIs) and their chemical...